RxDoctor Payments Data

Robin Johnson

Registered Nurse · Oklahoma City, OKNPI 1891020889

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novo Nordisk at 28.2% of the total. Reporting peaked in 2022 at $321 and has fallen 59.4% since, to $130 in 2025.

$1,002in general payments, 2019–2025

Across 63 payments — averaging $15.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$282
  • Pfizer$98
  • Merck$96
  • AbbVie$77
  • Lilly USA, LLC$70
  • Boehringer Ingelheim$65
  • plus $314 from 14 others

What the payments were for

  • Food & beverage$1,002100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,002 in reported general payments places this provider in the 85th percentile of 23 registered nurse providers in Oklahoma.

See all registered nurse providers in Oklahoma

Other registered nurse in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →